Predicting Chemo Benefit in Breast Cancer With EndoPredict Predicting Chemo Benefit in Breast Cancer With EndoPredict
Can a clinicomolecular score reliably predict absolute benefit of chemotherapy in women with HER2-negative, ER-positive breast cancer?JCO Precision Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Health | Hematology | HER2 | Women